PKU GOLIKE
Sponsors
APR Applied Pharma Research s.a.
Conditions
Phenylketonurias
Unknown Phase
Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute.
CompletedNCT05487378
Start: 2023-06-30End: 2024-05-26Updated: 2026-02-23
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
TerminatedNCT05827536
Start: 2023-10-30End: 2024-11-27Updated: 2026-03-11